A new research ecosystem has been set up in Finland in which the country’s leading research organisations, together with the Finnish Red Cross Blood Service, Orion Pharma and nanotechnology SMEs, are joining forces to develop new types of nanobiotechnological solutions for the treatment and early diagnostics of severe progressive diseases.

Read more on the Finnish Red Cross Blood Service webpage:
https://www.bloodservice.fi/news/new-pharmaceutical-research-utilising-nanobiotechnology-in-finland1